The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 20

More JCP Articles

JCP
The Role of Digital Phenotyping in Negative Symptoms Treatment Studies
Insights

October 31, 2024

In this video, Philip D. Harvey, PhD explores the use of digital phenotyping to track negative symptoms in schizophrenia. Through ecological momentary assessments (EMA) using GPS and actigraphy, the…
JCP
Anticholinergic Burden in Schizophrenia
Insights

October 31, 2024

In this video, Philip D. Harvey, PhD discusses anticholinergic burden in schizophrenia, highlighting its cognitive impact, particularly memory impairments linked to M1 receptor blockade. He underscores the heightened dementia…
JCP
Cannabis Use in Pregnancy and Adverse Outcomes
Clinical and Practical Psychopharmacology

October 30, 2024

This article focuses on the use of cannabis by women during the reproductive lifespan and specifically during pregnancy, and maternal and neonatal outcomes associated with exposure. Two recent large…
JCP
Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients
Original Research

October 30, 2024

The disparities in buprenorphine prescriptions and in outpatient medical visit access between sexually and gender diverse (SGD) and non-SGD cohorts found in this study highlight priorities for culturally responsive…
, , , et al
JCP
Suicide Crisis Syndrome Assessment and ED Readmission
Original Research

October 23, 2024

Diagnosis of suicide crisis syndrome reduced readmission risk by approximately 72% for any reason and almost 75% for suicidal presentations.
, , , et al
JCP
Prevalence, Correlates, and Burden of Subthreshold PTSD in US Veterans
Original Research

October 23, 2024

Subthreshold PTSD affects 3.5% of US military veterans and is associated with increased rates of psychiatric disorders, suicidal thoughts and behaviors, and functional difficulties.
, , , et al
JCP
Symptomatic Remission and Overall Recovery From BPD
Original Research

October 23, 2024

Over 24 years, patients with BPD were significantly slower to achieve remission or recovery than patients with other personality disorders. Ultimately, however, both groups achieved similarly high rates of…
, , , et al
JCP
Gepirone-ER and Sexual Function in Patients with MDD
Original Research

October 21, 2024

Rates of sexual side effects and treatment-emergent sexual dysfunction with gepirone-ER were similar to placebo and lower than sexual side effects reported for SSRIs.
, ,
JCP
Detecting Misuse of Prescription Opioids
Letter to the Editor

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.
, ,
JCP
Fluctuating ADHD in the Multimodal Treatment of ADHD (MTA) Study
Original Research

October 16, 2024

This study demonstrates that ADHD fluctuations are common and substantive and that, when remitted, individuals with fluctuating ADHD can successfully manage increased responsibilities.
, , , et al
JCP
Cannabis and Attention Deficit Disorder in Community Mental Health
Brief Report

October 14, 2024

The finding that 73% of patients with both ADHD and cannabis use were prescribed stimulant medications necessitates enhanced training and education for clinicians on appropriate prescription of stimulants.
, , , et al
JCP
Clinical Implications of Adult ADHD: What New Data Tell Us
Commentary

October 10, 2024

The authors discuss striking new findings from the Morbidity and Mortality Weekly Report on the burden of adult ADHD, demonstrating the need for the upcoming APSARD Adult ADHD Guidelines.
,

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe